Table 1.
Characteristic | Full Sample (N = 55) |
|
||
---|---|---|---|---|
Treatment Group | ||||
| ||||
Placebo (N = 21) | Intermittent (21-7) DROS/EE (N = 17) | Continuous DROS/EE (N = 16) | ||
Age | 32.5 (7.7) | 32.2 (8.6) | 32.1 (6.7) | 33.2 (8.1) |
Race | ||||
White | 65.5% | 63.6% | 52.9% | 81.3% |
Black | 23.6% | 27.3% | 35.3% | 6.3% |
Latina | 3.6% | 0.0% | 5.9% | 0.0% |
Asian | 7.3% | 9.1% | 5.9% | 12.5% |
Mixed or Other | 0.0% | 0.0% | 0.0% | 0.0% |
Marital Status | ||||
Single | 52.7% | 52.7% | 54.5% | 52.9% |
Married | 47.3% | 47.3% | 45.5% | 47.1% |
Smoking Status | ||||
Nonsmoker | 96.4% | 95.5% | 100.0% | 93.8% |
Smoker | 3.6% | 4.5% | 0.0% | 6.3% |